SEK45.10
1.83% yesterday
Stockholm, Sep 03, 05:29 pm CET
ISIN
SE0000163628
Symbol
EKTA B

Elekta AB Stock price

SEK45.10
-1.64 3.51% 1M
-14.55 24.39% 6M
-16.05 26.25% YTD
-22.00 32.79% 1Y
-14.30 24.07% 3Y
-70.31 60.92% 5Y
-13.05 22.44% 10Y
+30.55 209.97% 20Y
Stockholm, Closing price Wed, Sep 03 2025
-0.84 1.83%
ISIN
SE0000163628
Symbol
EKTA B

Key metrics

Basic
Market capitalization
SEK18.3b
Enterprise Value
SEK23.3b
Net debt
SEK5.0b
Cash
SEK2.8b
Shares outstanding
382.1m
Valuation (TTM | estimate)
P/E
63.8 | 12.5
P/S
1.0 | 1.0
EV/Sales
1.3 | 1.3
EV/FCF
14.7
P/B
2.0
Dividends
DPS
SEK1.20
Yield 1Y | 5Y
2.6% | 2.0%
Growth 1Y | 5Y
-50.0% | -7.7%
Payout 1Y | 3Y
35.2% | 67.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
SEK17.8b | SEK18.1b
EBITDA
SEK3.6b | SEK3.8b
EBIT
SEK1.9b | SEK2.4b
Net Income
SEK274.0m | SEK1.4b
Free Cash Flow
SEK1.6b
Growth (TTM | estimate)
Revenue
-1.5% | 0.4%
EBITDA
29.2% | -27.8%
EBIT
-15.8% | 16.9%
Net Income
-75.8% | 492.1%
Free Cash Flow
92.4%
Margin (TTM | estimate)
Gross
37.6%
EBITDA
20.2% | 21.2%
EBIT
10.4%
Net
1.5% | 7.8%
Free Cash Flow
8.9%
Financial Health
Equity Ratio
30.4%
Return on Equity
2.7%
ROCE
11.3%
ROIC
5.7%
Debt/Equity
0.9
More
EPS
SEK0.7
FCF per Share
SEK4.1
Short interest
-
Employees
5k
Rev per Employee
SEK4.0m
Show more

Is Elekta AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Elekta AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Elekta AB forecast:

3x Buy
14%
9x Hold
43%
9x Sell
43%

Analyst Opinions

21 Analysts have issued a Elekta AB forecast:

Buy
14%
Hold
43%
Sell
43%

Financial data from Elekta AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
17,838 17,838
2% 2%
100%
- Direct Costs 11,123 11,123
3% 3%
62%
6,715 6,715
1% 1%
38%
- Selling and Administrative Expenses 3,016 3,016
2% 2%
17%
- Research and Development Expense -11 -11
101% 101%
0%
3,603 3,603
29% 29%
20%
- Depreciation and Amortization 1,749 1,749
197% 197%
10%
EBIT (Operating Income) EBIT 1,854 1,854
16% 16%
10%
Net Profit 274 274
76% 76%
2%

In millions SEK.

Don't miss a Thing! We will send you all news about Elekta AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Jonas Bolander
Employees 4,541
Founded 1972
Website www.elekta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today